Work

444 Novel 2,3-dihydroimidazo[1,2-c]quinazolines PI3K inhibitors: Discovery and SAR

Year: 2010

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(10)72151-0

Authors: W.J. Scott, M. Hentemann, B. Rowley, C. Bull, A.M. Bullion, J. Johnson, A. Redman, N. Liu, R. Jones, E. Sibley

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2067167450

Cites:

Cited by: 1

Related to: 10